Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
INVEST: INternational VErapamil SR Trandolapril STudy
This study has been completed.
Study NCT00133692 Information provided by University of Florida
First Received: August 22, 2005 Last Updated: July 26, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Coronary Artery Disease
Additional conditions recognized in this trial
Coronary Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
Atenolol/HCTZ/Trandolapril
Additional drug interventions recognized in this trial
Atenolol
Diltiazem
Hydrochlorothiazide
Trandolapril
Verapamil
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Antihypertensive Agents
Autonomic Agents
Calcium Channel Blockers
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sodium Chloride Symporter Inhibitors
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Florida
Abbott
Back to top of Main Content
